RT Journal Article
SR Electronic
T1 BugSigDB captures patterns of differential abundance across a broad range of host-associated microbial signatures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.24.22281483
DO 10.1101/2022.10.24.22281483
A1 Geistlinger, Ludwig
A1 Mirzayi, Chloe
A1 Zohra, Fatima
A1 Azhar, Rimsha
A1 Elsafoury, Shaimaa
A1 Grieve, Claire
A1 Wokaty, Jennifer
A1 Gamboa-Tuz, Samuel David
A1 Sengupta, Pratyay
A1 Hecht, Isaac
A1 Ravikrishnan, Aarthi
A1 Gonçalves, Rafael
A1 Franzosa, Eric
A1 Raman, Karthik
A1 Carey, Vincent
A1 Dowd, Jennifer B.
A1 Jones, Heidi E.
A1 Davis, Sean
A1 Segata, Nicola
A1 Huttenhower, Curtis
A1 Waldron, Levi
YR 2023
UL http://medrxiv.org/content/early/2023/07/18/2022.10.24.22281483.abstract
AB The literature of human and other host-associated microbiome studies is expanding rapidly, but systematic comparisons among published results of host-associated microbiome signatures of differential abundance remain difficult. We present BugSigDB, a community-editable database of manually curated microbial signatures from published differential abundance studies, accompanied by information on study geography, health outcomes, host body site, and experimental, epidemiological, and statistical methods using controlled vocabulary. The initial release of the database contains >2,500 manually curated signatures from >600 published studies on three host species, enabling high-throughput analysis of signature similarity, taxon enrichment, co-occurrence and co-exclusion, and consensus signatures. These data allow assessment of microbiome differential abundance within and across experimental conditions, environments, or body sites. Database-wide analysis reveals experimental conditions with the highest level of consistency in signatures reported by independent studies and identifies commonalities among disease-associated signatures including frequent introgression of oral pathobionts into the gut.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 5R01CA230551 (to LW, NS, CH, and HJ) and 5U24CA180996 (to LW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes